# Predictive Factors for Outcomes of Fruquintinib Plus Immunotherapy in Colorectal Cancer

> **NCT05635149** · — · UNKNOWN · sponsor: **Union Hospital, Tongji Medical College, Huazhong University of Science and Technology** · enrollment: 100 (estimated)

## Conditions studied

- Colorectal Adenocarcinoma

## Interventions

- **RADIATION:** radiotherapy

## Key facts

- **NCT ID:** NCT05635149
- **Lead sponsor:** Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-01
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-09-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05635149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05635149, "Predictive Factors for Outcomes of Fruquintinib Plus Immunotherapy in Colorectal Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05635149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*